Answers are grounded in this paper and cite their sources.
Autosomal recessive mutations in the Parkin gene ( PRKN ) cause early-onset Parkinson’s disease (PD). Parkin functions as a ubiquitin E3 ligase acting downstream of the PINK1 kinase to promote phosphorylated ubiquitin at sites of mitochondrial damage. Yet the functional effects of most PRKN gene variants remain unknown. Here, we use a pooled cellular assay measuring phosphorylated ubiquitin accumulation to quantify the activity of ~9200 PRKN missense and nonsense variants. Our screen identifies thousands of loss- and gain-of-function variants, including activating variants mainly residing at autoinhibitory interfaces. Functional scores accurately distinguish known PD pathogenic and benign variants, providing evidence of pathogenicity or benignity for 175/182 variants of uncertain significance (VUS). When combined into biallelic genotype scores, these data predict the age at disease onset in patients, revealing a quantitative link between Parkin activity and clinical manifestation. Our results provide a comprehensive functional genetic map of Parkin and demonstrate the power of multiplexed assays of variant effects (MAVEs) for variant interpretation and precision medicine in PD.
No takes yet. Share an insight, caveat, or question.
Aslanzadeh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: